Volume 14, Issue 5, Pages (May 2001)

Slides:



Advertisements
Similar presentations
Volume 15, Issue 2, Pages (August 2001)
Advertisements

Volume 19, Issue 3, Pages (September 2003)
Volume 18, Issue 5, Pages (May 2003)
Volume 5, Issue 3, Pages (September 1996)
Volume 18, Issue 6, Pages (June 2003)
Marc Hertz, David Nemazee  Immunity 
Volume 7, Issue 6, Pages (December 1997)
Ling Lin, Jonathan D. Hron, Stanford L. Peng  Immunity 
Maternal-Derived Hepatitis B Virus e Antigen Alters Macrophage Function in Offspring to Drive Viral Persistence after Vertical Transmission  Yongjun Tian,
Volume 87, Issue 6, Pages (December 1996)
The Roles of Fas/APO-1 (CD95) and TNF in Antigen-Induced Programmed Cell Death in T Cell Receptor Transgenic Mice  Huey-Kang Sytwu, Roland S Liblau, Hugh.
Volume 15, Issue 1, Pages (July 2001)
Volume 11, Issue 5, Pages (November 1999)
Volume 29, Issue 6, Pages (December 2008)
Volume 34, Issue 1, Pages (January 2011)
Volume 18, Issue 4, Pages (April 2003)
Volume 18, Issue 2, Pages (February 2003)
Cellular Mechanisms of Fatal Early-Onset Autoimmunity in Mice with the T Cell-Specific Targeting of Transforming Growth Factor-β Receptor  Julien C. Marie,
Volume 87, Issue 6, Pages (December 1996)
Local Expression of TNFα in Neonatal NOD Mice Promotes Diabetes by Enhancing Presentation of Islet Antigens  E.Allison Green, Elizabeth E. Eynon, Richard.
Volume 1, Issue 4, Pages (May 2002)
Balthazar B Cazac, Jürgen Roes  Immunity 
Volume 19, Issue 2, Pages (August 2003)
Mark H Kaplan, Ulrike Schindler, Stephen T Smiley, Michael J Grusby 
Volume 16, Issue 4, Pages (April 2002)
Lymphoproliferation in CTLA-4–Deficient Mice Is Mediated by Costimulation-Dependent Activation of CD4+ T Cells  Cynthia A Chambers, Timothy J Sullivan,
Volume 24, Issue 3, Pages (March 2006)
Jürgen Ruland, Gordon S Duncan, Andrew Wakeham, Tak W Mak  Immunity 
Aiolos Regulates B Cell Activation and Maturation to Effector State
Impaired Development of Th2 Cells in IL-13-Deficient Mice
Volume 20, Issue 1, Pages (January 2004)
CD22 is a negative regulator of B-cell receptor signalling
Volume 37, Issue 4, Pages (October 2012)
Pax5/BSAP Maintains the Identity of B Cells in Late B Lymphopoiesis
Volume 11, Issue 2, Pages (August 1999)
Yang Xu, Genhong Cheng, David Baltimore  Immunity 
Volume 7, Issue 1, Pages (July 1997)
Volume 25, Issue 5, Pages (November 2006)
Volume 8, Issue 1, Pages (January 1998)
Both E12 and E47 Allow Commitment to the B Cell Lineage
Volume 27, Issue 5, Pages (November 2007)
Volume 27, Issue 3, Pages (September 2007)
Volume 4, Issue 4, Pages (April 1996)
Volume 33, Issue 2, Pages (August 2010)
The MAGUK Family Protein CARD11 Is Essential for Lymphocyte Activation
Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease  Leonid Gorelik, Richard A Flavell  Immunity 
Volume 84, Issue 4, Pages (February 1996)
Ludovica Bruno, Hans Jörg Fehling, Harald von Boehmer  Immunity 
A Prematurely Expressed Igκ Transgene, but Not a VκJκ Gene Segment Targeted into the Igκ Locus, Can Rescue B Cell Development in λ5-Deficient Mice  Roberta.
Volume 17, Issue 4, Pages (October 2002)
IgH Class Switch Recombination to IgG1 in DNA-PKcs-Deficient B Cells
Impaired Development of Th2 Cells in IL-13-Deficient Mice
Negative Selection of Immature B Cells by Receptor Editing or Deletion Is Determined by Site of Antigen Encounter  Peter C Sandel, John G Monroe  Immunity 
Volume 19, Issue 4, Pages (October 2003)
Volume 25, Issue 6, Pages (December 2006)
The MAGUK Family Protein CARD11 Is Essential for Lymphocyte Activation
Volume 8, Issue 1, Pages (January 1998)
Volume 85, Issue 5, Pages (May 1996)
Identification of Anergic B Cells within a Wild-Type Repertoire
Volume 14, Issue 1, Pages (January 2001)
CD83 Expression Influences CD4+ T Cell Development in the Thymus
Volume 16, Issue 3, Pages (March 2002)
Negative Selection at the Pre-BCR Checkpoint Elicited by Human μ Heavy Chains with Unusual CDR3 Regions  Yoshiyuki Minegishi, Mary Ellen Conley  Immunity 
A Function of Fas-Associated Death Domain Protein in Cell Cycle Progression Localized to a Single Amino Acid at Its C-Terminal Region  Zi Chun Hua, Sue.
Volume 4, Issue 2, Pages (February 1996)
Volume 10, Issue 2, Pages (February 1999)
Thymocyte Glucocorticoid Resistance Alters Positive Selection and Inhibits Autoimmunity and Lymphoproliferative Disease in MRL-lpr/lprMice  Eva Tolosa,
Volume 4, Issue 5, Pages (May 1996)
Volume 13, Issue 21, Pages (October 2003)
Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease  Leonid Gorelik, Richard A Flavell  Immunity 
Presentation transcript:

Volume 14, Issue 5, Pages 561-571 (May 2001) Mice Lacking the Orphan G Protein-Coupled Receptor G2A Develop a Late-Onset Autoimmune Syndrome  Lu Q Le, Janusz H.S Kabarowski, Zhigang Weng, Anne B Satterthwaite, Eric T Harvill, Eric R Jensen, Jeff F Miller, Owen N Witte  Immunity  Volume 14, Issue 5, Pages 561-571 (May 2001) DOI: 10.1016/S1074-7613(01)00145-5

Figure 1 Targeting Vector for Homologous Recombination into the G2A Locus (A) Genomic organization of the wild-type G2A allele, structure of the G2A targeting vector, and predicted structure of the correctly targeted mutant allele. (B and C) Southern blot analysis of PstI-digested tail genomic DNA hybridized with the external probe B (B) for genotypic determination or with the internal probe A (C) to determine successful deletion of the G2A gene. (D) RT-PCR analysis of total RNA derived from splenic T cells (right panels) and BCR-ABL-transformed pre-B cells (left panels), using G2A-specific primers P1 and P2 Immunity 2001 14, 561-571DOI: (10.1016/S1074-7613(01)00145-5)

Figure 2 Normal T and B Lymphoid Development in G2A−/− Mice Flow cytometric analysis of thymic, splenic, lymph node, and bone marrow cells from 8-week-old wild-type mice (left panels) and 8-week-old G2A−/− mice (right panels). Proportions of cells in each quadrant are indicated as percentages Immunity 2001 14, 561-571DOI: (10.1016/S1074-7613(01)00145-5)

Figure 3 Enlargement of Lymphoid Organs and Disruption of Follicular Architecture in Older G2A-Deficient Mice (A) Peripheral lymph nodes and spleens from a typical 15-month-old G2A−/− mouse (right panel) and its wild-type littermate (left panel). (B) H&E-stained sections of lymph nodes from wild-type (upper panel) and G2A−/− (lower panel) mice. (C) PCR analysis of TCR (left panel) and Ig (right panel) rearrangement. Lanes 1–2, G2A−/− spleens; lanes 3–5, G2A−/− lymph nodes; lane 6, wild-type spleen; lane 7, DNA size markers (GIBCO). Pictures are representative of at least ten animals Immunity 2001 14, 561-571DOI: (10.1016/S1074-7613(01)00145-5)

Figure 4 Photomicrograph of Lung and Liver Sections from Wild-Type and G2A−/− Mice Stained with H&E Histology of lung (A) and liver (B) tissues from a typical 15-month-old wild-type mouse (lower panel) and a 15-month-old G2A−/− mouse (upper panel), showing perivascular infiltration of mononuclear cells. Three mice per group have been analyzed, and the representative microscopic views are presented. Right panels, 100×; left panels, 400× Immunity 2001 14, 561-571DOI: (10.1016/S1074-7613(01)00145-5)

Figure 5 Older G2A-Deficient Mice Develop an Autoimmune Syndrome (A) Serum immunoglobulin levels in wild-type and G2A−/− mice. Increased immunoglobulin levels of IgG1 and IgA (left panel) as well as elevated levels of both κ and λ light chains (right panel) in G2A−/− mice. (B) Paraffin sections of kidney tissue from wild-type (lower panels) and G2A−/− (upper panels) mice reveal glomerular immunoglobulin deposition. Left panels, 100×; right panels, 400×. (C) Indirect immunoflourescence analysis of serum autoantibodies in wild-type and G2A−/− mice. Autoantibodies reacting against nuclear antigens are present in serum from G2A−/− mice (left panels, [C1] and [C2]) but not in wild-type mice (right panels, [C3] and [C4]) Immunity 2001 14, 561-571DOI: (10.1016/S1074-7613(01)00145-5)

Figure 6 G2A−/− T Cells but Not B Cells Exhibit Hyperproliferative Responses to Antigen Receptors Crosslinking Stimulation In Vitro Proliferation of peripheral T cells from young wild-type and G2A−/− mice stimulated by various concentrations of anti-CD3ϵ antibody alone (A) or with CD28 costimulation (B). Proliferation was assessed in triplicate by [3H]thymidine incorporation during the last 12 hr of culture. FACS analysis of propidium iodide-stained G2A−/− (C) and wild-type (D) T cells 36 hr following anti-CD3ϵ stimulation. Equal proliferative responses of splenic B cells from wild-type and G2A−/− mice by anti-IgM crosslinking (E) or LPS (F) Immunity 2001 14, 561-571DOI: (10.1016/S1074-7613(01)00145-5)

Figure 7 Self-Reactive, Hyperresponsive, and Altered Threshold of TCR-Dependent Activation in G2A−/− T Cells Syngeneic (A) and allogenic (B) mixed lymphocyte reactions using lymph node T cells (from 6- to 8-week-old mice) as responder cells and autologous splenic B cells or B6-derived B cells as stimulators. (C) Kinetics of stimulation of wild-type and G2A−/− T cells by 5 μg/ml anti-CD3ϵ antibody. T cell proliferation was assessed in triplicate by measurement of [3H]thymidine incorporation during a 12 hr period ending at the indicated time points following stimulation Immunity 2001 14, 561-571DOI: (10.1016/S1074-7613(01)00145-5)